The importance of oestrogens in males

Clinical Endocrinology

Volumn 58, Issue 5, 2003, Pages 529-542

  De Ronde, Willem ^a   Pols, Huibert A P ^a   Van Leeuwen, Johannes P T M ^a   De Jong, Frank H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANDROGEN; ANTIESTROGEN; AROMATASE; AROMATASE INHIBITOR; CLOMIFENE; ESTRADIOL; ESTRADIOL RECEPTOR; ESTROGEN; ESTROGEN BINDING PROTEIN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; GONADORELIN; GONADOTROPIN; SEX HORMONE; TAMOXIFEN; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; TRANSCRIPTION FACTOR;

BONE MASS; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; CLINICAL EXAMINATION; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME SYNTHESIS; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; ESTROGEN SYNTHESIS; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; KNOCKOUT MOUSE; LIPID METABOLISM; MALE FERTILITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

17-HYDROXYSTEROID DEHYDROGENASES; AROMATASE; BONE AND BONES; BRAIN; CARDIOVASCULAR DISEASES; ESTRADIOL; ESTROGENS; GONADS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIPID METABOLISM; MALE; RECEPTORS, ESTROGEN; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0038332174     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01669.x     Document Type: Review

References (172)

1. Adamski, J. & Jakob, F.J. (2001) A guide to 17β-hydroxysteroid dehydrogenases. Molecular and Cellular Endocrinology, 171, 1-4.
2. Aiginger, P., Kolbe, H., Kuhbock, J., Spona, J. & Geyer, G. (1981) The endocrinology of testicular germinal cell tumours. Acta Endocrinologica, 97, 419-426.
3. Amin, S., Zhang, Y., Sawin, C.T., Evans, S.R., Hannan, M.T., Kiel, D.P., Wilson, P.W.F. & Felson, D.T. (2000) Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Annals of Internal Medicine, 133, 951-963.
4. Arts, J., Kuiper, G.G.J.M., Janssen, J.M.M.F., Gustafsson, J.-A., Lowik, C.W.G.M., Pols, H.A.P. & van Leeuwen, J.P.T.M. (1997) Differential expression of oestrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology, 138, 5067-5070.9
5. Baird, D.T., Horton, R., Longcope, C. & Tait, J.F. (1969a) Steroid dynamics under steady-state conditions. Recent Progress in Hormone Research, 25, 611-664.
6. Baird, D.T., Uno, A. & Melby, J.C. (1969b) Adrenal secretion of androgens and oestrogens. Journal of Endocrinology, 45, 135-136.
7. Barrett-Connor, E. & Khaw, K.T. (1988) Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation, 78, 539-545.
8. Barrett-Connor, E., Goodman-Gruen, D. & Patay, B. (1999) Endogenous sex hormones and cognitive function in older men. Journal of Clinical Endocrinology and Metabolism, 84, 3681-3685.
9. Barrett-Connor, E., Mueller, J.E., von Muhlen, D.G., Laughlin, G.A., Schneider, D.L. & Sartotius, D.J. (2000) Low levels of oestradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo study. Journal of Clinical Endocrinology and Metabolism, 85, 219-223.
10. Bartsch, W., Horst, H.-J., Becker, H. & Nehse, G. (1977) Sex hormone binding globulin binding capacity, testosterone, 5α-dihydrotestosterone, ooestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment. Acta Endocrinologica, 85, 650-664.
11. van den Beld, A.W., de Jong, F.H., Grobbee, D.E., Pols, H.A. & Lamberts, S.W.J. (2000) Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. Journal of Clinical Endocrinology and Metabolism, 85, 3276-3282.
12. Berkovitz, G.D., Guerami, A., Brown, T.R., MacDonald, P.C. & Migeon, C.J. (1985) Familial gynecomastia with increased extraglandular aromatization of plasma cardon-19 steroids. Journal of Clinical Investigation, 75, 1763-1769.
13. Bertelloni, S., Baroncelli, G.I., Federico, G., Cappa, M., Lala, R. & Saggese, G. (1998) Altered bone mineral density in patients with complete androgen insensitivity syndrome. Hormone Research, 50, 309-314.
14. Bilezikian, J.P., Morishima, A., Bell, J. & Grumbach, M.M. (1998) Increased bone mass as a result of oestrogen therapy in a man with aromatase deficiency. New England Journal of Medicine, 339, 599-603.
15. Blackard, C.E., Doe, R.P., Mellinger, G.T. & Byar, D.P. (1970) Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate. Cancer, 26, 249-256.
16. Blum, A., Hathaway, L., Mincemoyer, R., Schenke, W.H., Csako, G., Waclawiw, M.A., Panza, J.A. & Cannon, R.O. (2000) Hormonal, lipoprotein, and vascular effects of the selective estrogen receptor modulator raloxifene in hypercholesterolic men. American Journal of Cardiology, 85, 1491-1494.
17. Blumenthal, R.S., Heldman, A.W., Brinker, J.A., Resar, J.R., Coombs, V.J., Gloth, S.T., Gerstenblith, G. & Reis, S.E. (1997) Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men. American Journal of Cardiology, 80, 1021-1024.
18. Boehmer, A.L.M., Brinkmann, A.O., Sandkuijl, L.A. (1999) 17β-hydroxysteroid dehydrogenase 3 deficiency: diagnosis, phenotypic variability, population genetics and world-wide distribution of ancient and de novo mutations. Journal of Clinical Endocrinology and Metabolism, 84, 4713-4721.
19. Boyar, R.M., Nogeire, C., Fukushima, D., Hellman, L. & Fishman, J. (1977) Studies of the diurnal pattern of plasma corticosteroids and gonadotrophins in two cases of feminizing adrenal carcinoma: measurement of oestrogen and corticosteroid production. Journal of Clinical Endocrinology and Metabolism, 44, 39-45.
20. Braidman, I., Baris, C., Wood, L., Selby, P., Adams, J., Freemont, A. & Hoyland, J. (2000) Preliminary evidence for impaired estrogen receptor-α protein expression in osteoblasts and osteocytes from men with idiopathic osteoporosis. Bone, 26, 423-427.
21. Braidman, I.P., Hainey, L., Batra, G., Selby, P.L., Saunders, P.T.K. & Hoyland, J.A. (2001) Localization of estrogen receptor α protein expression in adult human bone. Journal of Bone and Mineral Research, 16, 214-220.
22. Bulun, S.E. & Simpson, E.R. (1994) Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increases with advancing age. Journal of Clinical Endocrinology and Metabolism, 78, 428-432.
23. Bulun, S.E., Noble, L.S., Takayama, K., Michael, M.D., Agarwal, V., Fisher, C., Zhao, Y., Hinshelwood, M.M., Ito, Y. & Simpson, E.R. (1997) Endocrine disorders associated with inappropriately high aromatase expression. Journal of Steroid Biochemistry and Molecular Biology, 61, 133-139.
24. Bulusu, N.V., Lewis, S.B., Das, S. & Clayton, W.E. (1982) Serum lipid changes after oestrogen therapy in prostatic carcinoma. Urology, 20, 147-150.
25. Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K.S. & Simpson, E.R. (1997) Effect of testosterone and oestradiol in a man with aromatase deficiency. New England Journal of Medicine, 337, 91-95.
26. Carlsen, C.G., Soerensen, T.H. & Eriksen, E.F. (2000) Prevalence of low serum estradiol levels in male osteoporosis. Osteoporosis International, 11, 697-701.
27. Cauley, J.A., Gutai, J.P., Kuller, L.H. & Dai, W.S. (1987) Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. American Journal of Cardiology, 60, 771-777.
28. Chambliss, K.L., Yuhanna, I.S., Mineo, C., Liu, P., German, Z., Sherman, T.S., Mendelsohn, M.E., Anderson, R.G.W. & Shaul, P.W. (2000) Estrogen receptor α and endothelial nitric oxide synthase are organized into a functional signalling module in caveolae. Circulation Research, 87, 677-682.
29. Chester, A.H., Jiang, C., Borland, J.A., Yacoub, M.H. & Collins, P. (1995) Oestrogen relaxes human epicardial coronary arteries through nonendothelium-dependent mechanisms. Coronary Artery Disease, 6, 417-422.
30. Chute, C.G., Baron, J.A., Plymate, S.R., Kiel, D.P., Pavia, A.T., Lozner, E.C., O'Keefe, T. & MacDonald, G.J. (1987) Sex hormones and coronary artery disease. American Journal of Medicine, 83, 853-859.
31. Collins, P., Rosano, G.M.C., Sarrel, P.M., Ulrich, L., Adamopoulos, S., Beale, C.M., McNeill, J.G. & Poole-Wilson, P.A. (1995) 17α-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not in men with coronary heart disease. Circulation, 92, 24-30.
32. Coronary Drug Project Research Group. (1973) The Coronary Drug Project: findings leading to discontinuation of the 2-5 mg day estrogen group. Journal of the American Medical Association, 226, 652-657.
33. Couse, J.F. & Korach, K.S. (1999) Oestrogen receptor null mice: what have we learned and where will they lead us? Endocrine Reviews, 20, 358-417.
34. Cunningham, C.J., Sinnot, M., Denihan, A., Rowan, M., Walsh, J.B., O'Moore, R., Coakley, D., Coen, F., Lawler, B.A. & O'Neill, D.D. (2001) Endogenous sex hormone levels in postmenopausal women with alzheimer's disease. Journal of Clinical Endocrinology and Metabolism, 86, 1099-1103.
35. Cutler, G.B. (1997) The role of oestrogen in bone growth and maturation during childhood and adolescence. Journal of Steroid Biochemistry and Molecular Biology, 61, 141-144.
36. Daniell, H.W. (1997) Osteoporosis after orchiectomy for prostate cancer. Journal of Urology, 157, 439-444.
37. Deladoey, J., Fluck, C., Bex, M., Yoshimura, N., Harada, N. & Mullis, P.E. (1999) Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent oestrogen production on serum gonadotropin concentration in a boy. Journal of Clinical Endocrinology and Metabolism, 84, 4050-4054.
38. Dony, J.M.J., Smals, A.G.H., Rolland, R., Fauser, B.C.J.M. & Thomas, C.M.G. (1985) Effect of lower versus higher doses of tamoxifen on pituitary-gonadal function and sperm indices in oligozoospermic men. Andrologia, 17, 369-378.
39. Drafta, D., Schindler, A.E., Stroe, E. & Neacsu, E. (1982) Age-related changes of plasma steroids in normal adult males. Journal of Steroid Biochemistry, 17, 683-687.
40. Dunn, J.F., Nisula, B.C. & Rodbard, D. (1981) Transport of steroid hromones: binding of 21 endogenous steroids to both testosterone-binding globulin and cortcosteroid-binding globulin in human plasma. Journal of Clinical Endocrinology and Metabolism, 53, 58-68.
41. Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P. & Mark, M. (2000) Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes. Development, 127, 4277-4291.
42. Eddy, E.M., Washburn, T.F., Bunch, D.O., Goulding, E.H., Gladen, B.C., Lubahn, D.B. & Korach, K.S. (1996) Targeted disruption of the oestrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology, 137, 4796-4805.
43. Eldrup, E., Winkel, P., Lindholm, J., Bentzon, M.W., Jensen, G. & Schnohr, P. (1989) Coronary risk factors, development of myocardial infarction, and plasma ooestrogens: a prospective case-control study in men. Journal of Internal Medicine, 225, 367-372.
44. Eriksson, M., Berglund, L., Rudling, M., Henriksson, P. & Angelin, B. (1989) Effects of oestrogen on low density lipiprotein metabolism in males. Journal of Clinical Investigation, 84, 802-810.
45. Faiman, C. & Winters, J.S.D. (1974) The control of gonadotropin secretion in complete testicular feminization. Journal of Clinical Endocrinology and Metabolism, 39, 631-638.
46. Falahati-Nini, A., Riggs, B.L., Atkinson, E.J., O'Fallon, W.M., Eastell, R. & Khosla, S. (2000) Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. Journal of Clinical Investigation, 106, 1553-1560.
47. Feix, M., Wolf, L. & Schweikert, H.U. (2001) Distribution of 17β-hydroxysteroid dehydrogenases in human osteoblast-like cells. Molecular and Cellular Endocrinology, 171, 163-164.
48. Ferrini, R.L. & Barret-Connor, E. (1998) Sex hormones and age: a cross-sectional study of testosterone and oestradiol and their bioavailable fractions in community-dwelling men. American Journal of Epidemiology, 147, 750-754.
49. Field, A.E., Colditz, G.A., Willett, W.C., Longcope, C. & McKinlay, J.B. (1994) The relation of smoking, age, relative weight and dietary intake to serum steroids, sex hormones and sex hormone-binding globulin in middle-aged men. Journal of Clinical Endocrinology and Metabolism, 79, 1310-1316.
50. Fiet, J., Villette, J.M., Bertagna, C., de Gery, A., Hucher, M., Husson, J.M. & Raynaud, J.P. (1987) Plasma hormone levels before and after orchiectomy in prostate cancer patients. Progress in Clinical and Biological Research, 243A, 33-44.
51. Finkelstein, J.S., O'Dea, L.S.L., Whitcomb, R.W. & Crowley, W.F. (1991b) Sex steroid control of gonadotropin secretion in the human male. II. Effects of oestradiol administration in normal and gonadotropin-releasing hormone-deficient men. Journal of Clinical Endocrinology and Metabolism, 73, 621-628.
52. Finkelstein, J.S., Whitcomb, R.W., O'Dea, L.S.L., Longcope, C., Schoenfeld, D.A. & Crowley, W.F. (1991a) Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men. Journal of Clinical Endocrinology and Metabolism, 73, 609-620.
53. Fisher, C.R., Graves, K.H., Parlow, A.F. & Simpson, E.R. (1998) Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proceedings of the National Academy of Sciences USA, 95, 6965-6970.
54. Geissler, W.M., Davis, D.L., Wu, L., Bradshaw, K.D., Patel, S., Mendonca, B.B., Elliston, K.O., Wilson, J.D., Russell, D.W. & Andersson, S. (1994) Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nature Genetics, 7, 34-39.
55. Gillberg, P., Johansson, A.G. & Ljunghall, S. (1999) Decreased oestradiol levels and free androgen index and elevated sex hormone-binding globulin levels in male idiopathic osteoporosis. Calcified Tissue International, 64, 209-213.
56. Goldberg, R.J., Gore, J.M., Zive, M., Brady, P., Klaiber, E., Broverman, D., Ockene, I.S. & Dalen, J.E. (1987) Serum oestradiol and coronary artery disease. American Journal of Medicine, 82, 1-4.
57. Gordon, G.G., Olivo, J., Rafii, F. & Southern, A.L. (1975) Conversion of androgens to oestrogens in cirrhosis of the liver. Journal of Clinical Endocrinology and Metabolism, 40, 1018-1026.
58. Greendale, G.A., Edelstein, S. & Barret-Connor, E. (1997) Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. Journal of Bone and Mineral Research, 12, 1833-1842.
59. Haffner, S.M., Mykkanen, L., Valdez, R.A. & Katz, M.S. (1993) Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. Journal of Clinical Endocrinology and Metabolism, 77, 1610-1615.
60. Hamalainen, E., Adlercreutz, H., Ehnholm, C. & Puska, P. (1986) Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men. Metabolism, 35, 535-541.
61. Harada, N., Sasano, H., Murakami, H., Ohkuma, T., Nagura, H. & Takagi, Y. (1999) Localized expresiion of aromatase in human vascular tissues. Circulation Research, 84, 1285-1291.
62. Hayes, F.J., Seminara, S.B., Decruz, S., Boepple, P.A. & Crowley, W.F. Jr (2000) Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. Journal of Clinical Endocrinology and Metabolism, 85, 3027-3035.
63. Heller, R.F., Wheeler, M.J., Micallef, J., Miller, N.E. & Lewis, B. (1983) Relationship of high density lipoprotein cholesterol with total and free testosterone and sex hormone binding globulin. Acta Endocrinologica (Copenh), 104, 253-256.
64. Hemsell, D.L., Edman, C.D., Marks, J.F., Siiteri, P. & MacDonald, P.C. (1977) Massive extraglandular aromatization of plasma androsteendione resulting in feminization of a prepubertal boy. Journal of Clinical Investigation, 60, 455-464.
65. Hemsell, D.L., Grodin, J.M., Brenner, P.F., Siiteri, P.K. & MacDonald, P.C. (1974) Plasma precursors of oestrogen. II. Correlation of the extent of conversion of plasma androsteendione to oestrone with age. Journal of Clinical Endocrinology and Metabolism, 38, 476-479.
66. Henriksson, P., Angelin, B. & Berglund, L. (1992) Hormonal regulation of serum Lp (a) levels. Opposite effects after oestrogentreatment and orchiectomy in males with prostatic carcinoma. Journal of Clinical Investigation, 89, 1166-1171.
67. Henriksson, P., Einarsson, K., Eriksson, A., Kelter, U. & Angelin, B. (1989) Oestrogen-induced gallstone formation in males. Journal of Clinical Investigation, 84, 811-816.
68. Henriksson, P., Linde, B. & Edhag, E. (1987) Deleterious effects of low-dose ooestrogen therapy on coronary status in patients with prostatic cancer. European Heart Journal, 8, 779-784.
69. Hess, R.A., Bunick, D., Lubahn, D.B., Zhou, Q. & Bouma, J. (2000) Morphologic changes in efferent ductiles and epididymis in estrogen receptor-α knockout mice. Journal of Andrology, 21, 107-121.
70. Hess, R.A., Bunnick, D., Lee, K.H., Bahr, J., Taylor, J.A., Korach, K.S. & Lubhan, D.B. (1997) A role for oestrogens in the male reproductive system. Nature, 390, 509-512.
71. Hobbs, C.J., Jones, R.E. & Plymate, S.R. (1996) Nandrolone, a 19-nortestosterone, enhances insulin-independent glucose uptake in normal men. Journal of Clinical Endocrinology and Metabolism, 81, 1582-1585.
72. Honda, S., Harada, N., Ito, S., Takagi, Y. & Maeda, S. (1998) Disruption of sexual behaviour in male aromatase-deficient mice lacking exons 1 and 2 of the cyp19 gene. Biochemical and Biophysical Research Communications, 252, 445-449.
73. Hurn, P.D. & Macrae, I.M. (2000) Estrogen as a neuroprotectant in stroke. Journal of Cerebral Blood Flow and Metabolism, 20, 631-652.
74. Ishunina, T.A. & Swaab, D.F. (2001) Increased expression of estrogen receptor α and α in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiology of Aging, 22, 417-426.
75. Janssen, J.M.M.F., Bland, R., Hewison, M., Coughtrie, M.W.H., Sharp, S., Arts, J., Posl, H.A.P. & van Leeuwen, J.P.T.M. (1999) Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function. Journal of Cellular Biochemistry, 75, 528-537.
76. Jejuna, H.S., Karanth, S., Dutt, P. & Meherjee, P. (1991) Diurnal variations and temporal coupling of bioactive and immunoactive luteinizing hormone, prolactin, testosterone and 17-β-estradiol in adult men. Hormone Research, 35, 89-94.
77. Karl, M., Lamberts, S.W.J., Koper, J.W., Katz, D.A., Huizenga, N.A.T.M., Kino, T., Haddad, B.R., Hughes, M.R. & Chrousos, G.P. (1996) Cushing's disease preceded by generelized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proceedings of the Association of American Physicians, 108, 296-307.
78. van Kesteren, P., Lips, P., Gooren, L.J.G., Asscheman, H. & Megens, J. (1998) Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clinical Endocrinology, 48, 347-354.
79. Khaw, K.T. & Barrett-Connor, E. (1991) Endogenous sex hormones, high density lipoprotein cholesterol and other lipoprotein fractions in men. Arteriosclerosis and Thrombosis, 11, 489-494.
80. Khosla, S., Melton, L.J., Atkinson, E.J. & O'Fallon, W.M. (2001) Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. Journal of Clinical Endocrinology and Metabolism, 86, 3555-3561.
81. Khosla, S., Melton, L.J., Atkinson, E.J., O'Fallon, W.M., Klee, G.G. & Riggs, B.L. (1998) Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable oestrogen. Journal of Clinical Endocrinology and Metabolism, 83, 2266-2274.
82. Kim-Schulze, S., McGowan, K.A., Hubchak, S., Cid, M.C., Martin, M.B., Kleinman, H.K., Greene, G.L. & Schnaper, H.W. (1996) Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation, 94, 1402-1407.
83. Kley, H.K., Deselaers, T., Peerenboom, H. & Kruskemper, H.L. (1980a) Enhanced conversion of androsteendione to oestrogens in obese males. Journal of Clinical Endocrinology and Metabolism, 51, 1128-1132.
84. Kley, H.K., Edelmann, P. & Kruskemper, H.L. (1980b) Relationship of plasma sex hormones to different parameters of obesity in male subjects. Metabolism, 29, 1041-1045.
85. Knuth, U.A., Hano, R. & Nieschlag, E. (1984) Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men. Journal of Clinical Endocrinology and Metabolism, 59, 963-969.
86. Komesaroff, P.A., Fullerton, M., Esler, M.D., Dart, A., Jennings, G. & Sudhir, K. (2001) Low-dose estrogen supplementation improves vascular function in hypogonadal men. Hypertension, 38, 1011-1016.
87. Korach, K.S. (1994) Insights from the study of animals lacking functional oestrogen receptor. Science, 266, 1524-1527.
88. Krege, J.H., Hodgin, J.B., Couse, J.F., Enmark, E., Warner, M., Mahler, J.F., Sar, M., Korach, K.S., Gustafsson, J.-A. & Smithies, O. (1998) Generation and reproductive phenotypes of mice lacking oestrogen receptor β. Proceedings of the National Acadamy of Sciences USA, 95, 15677-15682.
89. Kuiper, G.G.J.M., Enmark, E., Pelto-Huikko, M., Nilsson, S. & Gustafsson, J.-A. (1996) Cloning of a novel oestrogen receptor expressed in rat prostate and ovary. Proceedings of the National Academy of Sciences USA, 93, 5925-5930.
90. Kuiper, G.G.J.M., van den Bemd, G.-J.C.M. & van Leeuwen, J.P.T.M. (1999) Oestrogen receptor and the SERM concept. Journal of Endocrinological Investigation, 22, 594-603.
91. Labrie, F. (1991) Intracrinology. Molecular and Cellular Endocrinology, 78, c113-c118.
92. Labrie, F., Belanger, A., Cusan, L. & Candas, B. (1997) Physiological changes in dehydroepiandrosterone are not reflected by serumlevels of active androgens and oestrogens but of their metabolites: intracrinology. Journal of Clinical Endocrinology, and Metabolism, 82, 2403-2409.
93. Laue, L., Jones, J., Barnes, K.M. & Cutler, G.B. (1993) Treatment of familial male precocious puberty with spirinolactone, testolactone and desorelin. Journal of Clinical Endocrinology and Metabolism, 76, 151-155.
94. Leav, I., Lau, K.M., Adams, J.Y., McNeal, J.E., Taplin, M.E., Wang, J., Singh, H. & Ho, S.M. (2001) Comparative studies of the estrogen receptors α and β and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. American Journal of Pathology, 159, 79-92.
95. Lichtenstein, M.J., Yarnell, M.J., Elwood, P.C., Beswick, A.D., Sweetnam, P.M., Marks, V., Teale, D. & Riad-Fahmy, D. (1987) Sex hormones, insulin, lipids and prevalent ischemic heart disease. American Journal of Epidemiology, 126, 647-657.
96. Lips, P., Asscheman, H., Uitewaal, P., Netelenbos, J.C. & Gooren, L. (1989) The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals. Journal of Bone and Mineral Research, 4, 657-662.
97. Longcope, C., Goldfield, S.R.W., Brambilla, D.J. & McKinlay, J. (1990) Androgens, oestrogens and sex hormone-binding globulin in middle-aged men. Journal of Clinical Endocrinology and Metabolism, 71, 1442-1446.
98. Longcope, C., Pratt, J.H. & Fineberg, E. (1984) Oestrogen and androgen dynamics in liver disease. Journal of Endocrinological Investigation, 7, 629-634.
99. Longcope, C., Pratt, J.H., Schneider, S.H. & Fineberg, S.E. (1978) Aromatization of androgens by muscle and adipose tissue in vivo. Journal of Endocrinology and Metabolism, 46, 146-152.
100. MacDonald, P.C., Madden, J.D., Brenner, P.F., Wilson, J.D. & Siiteri, P.K. (1979) Origin of oestrogen in normal men and in women with testicular feminisation. Journal of Clinical Endocrinology and Metabolism, 49, 905-916.
101. MacGregor, J.I. & Jordan, V.C. (1998) Basic guide to the mechanism of antioestrogen action. Pharmacological Reviews, 50, 151-196.
102. Mahato, D., Goulding, E.H., Korach, K.S. & Eddy, E.M. (2001) Estrogen receptor-α is required by the supporting somatic cells for spermatogenesis. Molecular and Cellular Endocrinology, 178, 57-63.
103. Makinen, S., Makela, S., Weihua, Z., Warner, M., Rosenlund, B., Salmi, S., Hovatta, O. & Gustafsson, J.K. (2001) Localization of oestrogen receptors α and β in human testis. Molecular Human Reproduction, 7, 497-503.
104. Marcus, R., Leary, D., Schneider, D.L., Shane, E., Favus, M. & Quigly, C.A. (2000) The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism, 85, 1032-1037.
105. Marynick, S.P., Loriaux, D.L., Sherins, R.J., Pita, J.C. & Lipsett, M.B. (1979) Evidence that testosterone can suppress pituitary gonadotropin secretion independently of peripheral aromatization. Journal of Clinical Endocrinology and Metabolism, 49, 396-398.
106. Meier, D.E., Orwoll, E.S., Keenan, E.J. & Fagerstrom, R.M. (1987) Marked decline in trabecular bone mineral content in healthy men with age: lack of association with sex steroid levels. Journal of the American Geriatics Society, 35, 189-197.
107. Mendelsohn, M.E. (2000) Nongenomic, estrogen receptor-mediated activation of endothelial nitric oxide synthase. How does it work? What does it mean? Circulation Research, 87, 956-960.
108. Mikkola, A.K., Ruutu, M.L., Aro, J.L., Rannikko, S.A. & Salo, J.O. (1998) Parenteral polyooestradiol phosphate vs orchiectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2-year follow-up report of a national, prospective prostatic cancer study. Finnprostate group. British Journal of Urology, 82, 63-68.
109. Moorjani, S., Dupont, A., Labrie, F., Lupien, P.-J., Gagne, C., Brun, D., Giguere, M., Belanger, A. & Cusan, L. (1988) Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, oestrogen and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide. Journal of Clinical Endocrinology and Metabolism, 66, 314-322.
110. Morishima, A., Grumbach, M.M., Simpson, E.R., Fisher, C. & Qin, K. (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of oestrogens. Journal of Clinical Endocrinology and Metabolism, 80, 3689-3698.
111. Mukherjee, T.K., Dinh, H., Chaudhuri, G. & Nathan, L. (2002) Testosterone attenuates expression of vascular adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. Proceedings of the National Academy of Sciences USA, 99, 4055-4060.
112. Murakami, H., Harada, N. & Sasano, H. (2001) Aromatase in atherosclerotic lesions of human aorta. Journal of Steroid Biochemistry and Molecular Biology, 79, 67-74.
113. Murono, E.P., Nankin, H.R., Lin, T. & Osterman, J. (1982) The aging Leydig cell V. Diurnal rhythms in aged men. Acta Endocrinologica, 99, 619-623.
114. Murphy, S., Khaw, K.-T., Cassidy, A. & Compston, J.E. (1993) Sex hormones and bone mineral density in elderly men. Bone and Mineral, 20, 133-140.
115. Nilsson, L.O., Boman, A., Savendahl, L., Grigelioniene, G., Ohlsson, C., Ritzen, E.M. & Wroblenski, J. (1999) Demonstration of estrogen receptor-β immunoreactivity in human growth plate cartilage. Journal of Clinical Endocrinology and Metabolism, 84, 370-373.
116. Nilsson, S., Mäkelä, S., Treuter, E., Tujague, M., Thomson, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M. & Gustafsson, J.A. (2001) Mechanisms of estrogen action. Physiological Reviews, 81, 1535-1565.
117. O'Donell, L., Robertson, K.M., Jones, M.E. & Simpson, E.R. (2001) Estrogen and spermatogenesis. Endocrine Reviews, 22, 289-318.
118. Ogawa, S., Chan, J., Chester, A.E., Gustafsson, J.-A., Korach, K.S. & Pfaff, D.W. (1999) Survival of reproductive behaviours in oestrogen receptor α gene-deficient (αERKO) male and female mice. Proceedings of the National Acadamy of Sciences USA, 96, 12887-12892.
119. Paja, M., Diez, S., Lucas, T., Ojeda, A., Salto, L. & Estrada, J. (1994) Dexamethasone-suppressible feminizing adrenal adenoma. Postgraduate Medical Jounal, 70, 584-588.
120. Parker, L.N., Gray, D.R., Lai, M.K. & Levin, E.R. (1986) Treatment of gynecomastia with tamoxifen: a double-blind crossover study. Metabolism, 35, 705-708.
121. Pasquali, D., Rossi, V., Esposito, D., Abbondanza, C., Puca, G.A., Bellasella, A. & Sinisi, A.A. (2001) Loss of estrogen receptor β expression in malignant prostate cells in primary cultures and in prostate cancer tissues. Journal of Clinical Endocrinology and Metabolism, 86, 2051-2055.
122. Pedersen, S.B., Bruun, J.M., Hube, F., Kristensen, K., Hauner, H. & Richelsen, B. (2001) Demonstration of estrogen receptor subtypes α and in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Molecular and Cellular Endocrinology, 182, 27-37.
123. Peltoketo, H., Luu-The, V., Simard, J. & Adamski, J. (1999) 17β-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17-HSD/KSR enzymes. Journal of Molecular Endocrinology, 23, 1-11.
124. Phillips, G.B., Yano, K. & Stemmerman, G.N. (1988) Serum sex hormone levels and myocardial infarction in the Honolulu heart program. Pitfalls in prospective studies on sex hormones. Journal of Clinical Epidemiology, 41, 1151-1156.
125. Price, J.F., Lee, A.J. & Fowkes, F.G.R. (1997) Steroid sex hormones and peripheral arterial disease in the Edinburgh artery study. Steroids, 62, 789-794.
126. Reis, S.E., Holubkov, R., Zell, K.A., Smith, A.J.C., Cohen, H.A., Feldman, M.D. & Blumenthal, R.S. (1998) Estrogen acutely abolishes abnormal cold-induced coronary constriction in men. Chest, 114, 1556-1561.
127. Robertson, K.M., O'Donnell, L., Jones, M.E.E., Maechem, S.J., Boon, W.C., Fisher, C.R., Graves, K.H., McLachlan, R.I. & Simpson, E.R. (1999) Impairment of spermatogenesis in mice lacking a functional aromatase (cyp19) gene. Proceedings of the National Academy of Sciences USA, 96, 7986-7991.
128. Saez, J.M., Morera, A.M., Dazord, A. & Bertrand, J. (1975) Adrenal and testicular contribution to plasma oestrogens. Journal of Endocrinology, 55, 41-49.
129. Santen, R.J. (1975) Is aromatization of testosterone to oestradiol requiered for inhibition of luteinizing hormone sexretion in men? Journal of Clinical Investigation, 56, 1555-1563.
130. Santen, R.J., Petroni, G.R., Fisch, M.J., Myers, C.E., Theodorescu, D. & Cohen, R.B. (2001) Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma. Cancer, 92, 2095-2101.
131. Schindler, A.E., Ebert, A. & Friedrich, E. (1972) Conversion of androstenedione to oestrone by human fat tissue. Journal of Clinical Endocrinology and Metabolism, 35, 627-630.
132. Schweikert, H.U., Milewich, L. & Wilson, J.D. (1975) Aromatization of androstenedione by isolated human hairs. Journal of Clinical Endocrinology and Metabolism, 40, 413-417.
133. Schweikert, H.-U., Wolf, L. & Romalo, G. (1995) Ooestrogen formation from androsteendione in human bone. Clinical Endocrinology, 43, 37-42.
134. Shupnik, M.A., Pitt, L.K., Soh, A.Y., Anderson, A., Lopes, M.B. & Laws, E.R. (1998) Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 83, 3965-3972.
135. Simon, D., Preziosi, P., Barret-Connor, E., Roger, M., Saint-Paul, M., Nahoul, K. & Papoz, L. (1992) The inluence of aging on plasma sex hormones in men: the Telecom study. American Journal of Epidemiology, 135, 783-791.
136. Simpson, E.R. & Davis, S.R. (2001) Minireview: Aromatase and the regulation of estrogen biosynthesis: some new perspectives. Endocrinology, 142, 4589-4594.
137. Slemenda, C.W., Longcope, C., Zhou, L., Hui, S.L., Peacock, M. & Johnston, C.C. (1997) Sex steroids and bone mass in older men. Journal of Clinical Investigation, 100, 1755-1759.
138. Small, M., Lowe, G.D.O., Beastall, G.H., Beattie, J.M., McEachern, M., Hutton, I., Lorimer, A.R. & Forbes, C.D. (1985) Serum ooestradiol and ischemic heart disease: realtionship with myocardial infarction but not coronary atheroma or haemostasis. Quarterly Journal of Medicine, 233, 775-782.
139. Smith, E.P., Boyd, J., Frank, G.R., Takahashi, H., Cohen, R.M., Specker, B., Williams, T.C., Lubahn, D.B. & Korach, K.S. (1994) Oestrogen resistance caused by a mutation in the oestrogen-receptor gene in a man. New England Journal of Medicine, 331, 1056-1061.
140. Soule, S.G., Conway, G., Prelevic, G.M., Prentice, M., Ginsburg, J. & Jacobs, H.S. (1995) Osteopenia as a feature of the androgen insensitivity syndrome. Clinical Endocrinology, 43, 671-675.
141. Stanik, S., Dornfeld, L.P., Maxwell, M.H., Viosca, S.P. & Korenman, S.G. (1981) The effect of weight loss on reproductive hormones in obese men. Journal of Clinical Endocrinology and Metabolism, 53, 828-832.
142. Stefanick, M.L., Williams, P.T., Krauss, R.M., Terry, R.B., Vranizan, K.M. & Wood, P.D. (1987) Relationships of plasma oestradiol, testosterone and sex hormone-binding globulin with lipoproteins, apolipoproteins and high density lipoprotein subfractions in men. Journal of Clinical Endocrinology and Metabolism, 64, 723-729.
143. Stepan, J.J., Lachman, M., Zverina, J., Pacovsky, V. & Baylink, D.J. (1989) Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. Journal of Clinical Endocrinology and Metabolism, 69, 523-527.
144. Sterzik, K., Rosenbusch, B., Heyden, M. & Lichtenberger, K. (1993) Tamoxifen treatment of oligozoospermia: a re-evaluation of its effects including additional sperm function tests. Archives of Gynaecology and Obstetrics, 252, 143-147.
145. Stewart-Bentley, M., Odell, W. & Horton, R. (1974) The feedback control of luteinizing hormone in normal adult men. Journal of Clinical Endocrinology and Metabolism, 38, 545-553.
146. Stoffel-Wagner, B., Watzka, M., Schramm, J., Bidlingmaier, F. & Klingmuller, D. (1999) Expression of CYP19 (aromatase) mRNA in different areas of the human brain. Journal of Steroid Biochemistry and Molecular Biology, 70, 237-241.
147. Strain, G.W., Zumoff, B., Kream, J., Strain, J.J., Deucher, R., Rosenfeld, R.S., Levin, J. & Fukushima, D.K. (1982) Mild hypogonadotropic hypogonadism in obese men. Metabolism, 31, 871-875.
148. Strain, G.W., Zumoff, B., Miller, L.K., Rosner, W., Levit, C., Kalin, M., Herschcopf, R.J. & Rosenfeld, R.S. (1988) Effect of massive weight
149. Sudhir, K. & Komesaroff, A. (1999) Cardiovascular actions of oestrogens in men. Journal of Clinical Endocrinology and Metabolism, 84, 3411-3415.
150. Sudhir, K., Chou, T.M., Chatterjee, K., Smith, E.P., Williams, T.C., Kane, J.P., Mallory, M.J., Korach, K.S. & Rubanyi, G.M. (1997a) Premature coronary artery diseaese associated with a disruptive mutation in the oestrogen receptor gene in a man. Circulation, 96, 3774-3777.
151. Sudhir, K., Chou, T.M., Messina, L.M., Hutchison, S.J., Korach, K.S., Chatterjee, K. & Rubanyi, G.M. (1997b) Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet, 349, 1146-1147.
152. Szulc, P., Munoz, F., Claustrat, B., Garnero, P., Marchand, F., Duboef, F. & Delmas, P.D. (2001) Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. Journal of Clinical Endocrinology and Metabolism, 86, 192-199.
153. Taggart, H., Sheridan, B. & Stout, R.W. (1980) Sex hormone levels in younger male stroke survivors. Atherosclerosis, 35, 123-125.
154. Taxel, P., Kennedy, D., Fall, P., Willard, A., Shoukri, K., Clive, J. & Raisz, L.G. (2000) The effect of short-term treatment with micronized estradiol on bone turnover and gonadotrophins in older men. Endocrine Research, 26, 381-398.
155. Thompson, E.A. & Siiteri, P.K. (1974) The involvement of human placental microsomal cytochrome P-450 in aromatization. Journal of Biological Chemistry, 249, 5373-5378.
156. Toda, K., Okada, T., Takeda, K., Akira, S., Saibara, T., Shiraishi, M., Onishi, S. & Shizuta, Y. (2001) Oestrogen at the neonatal stage is critical for the reproductive ability of male mice as reveled by supplementation with 17α-oestradiol to aromatase gene (CYP19) knockout mice. Journal of Endocrinology, 168, 455-463.
157. Ushiyama, T., Ueyama, H., Inoue, K., Ohkubo, I. & Hukuda, S. (1999) Expression of genes for estrogen receptors α and β in human articular chondrocytes. Osteoarthritis and Cartilage, 7, 560-566.
158. Veldhuis, J.D., Lizarralde, G. & Iranmanesh, A. (1992) Divergent effects of short term glucocorticoid excess on the gonadotrophic and somatotrophic axes in normal men. Journal of Clinical Endocrinology and Metabolism, 74, 96-102.
159. Veldhuis, J.D., Rogol, A.D., Samojlik, E. & Ertel, N.H. (1984) Role of endogenous opiates in the expression of negative feedback actions of androgen and oestrogen on pulsatile properties of luteinizing hormone secretion in man. Journal of Clincal Investigation, 74, 47-55.
160. Veldhuis, J.D., Urban, R.J. & Dufau, M.L. (1994) Differential responses of biologically active luteinizing hormone secretion in older versus young men to interruption of androgen-negative feedback. Journal of Clinical Endocrinology and Metabolism, 79, 1763-1770.
161. Verhelst, J., Denis, L., van Vliet, P., van Poppel, H., Braekman, J., van Cangh, P., Mattelaer, J., d'Hulster, D. & Mahler, Ch (1994) Endocrine profiles during administration of the new nonsteroidal antiandrogen Casodex in prostate cancer. Clinical Endocrinology, 41, 525-530.
162. Vermeulen, A. (1991) Androgens in the aging male. Journal of Clinical Endocrinology and Metabolism, 73, 221-224.
163. Vihko, P., Isomaa, V. & Ghosh, D. (2001) Structure and function of 17β-hydroxysteroid dehydrogenase type 1 and 2. Molecular and Cellular Endocrinology, 171, 71-76.
164. Wallentin, L. & Varenhorst, E. (1981) Plasma lipoproteins during antandrogen treatment by oestrogens or orchiectomy in men with prostatic carcinoma. Hormone Metabolism Research, 13, 293-297.
165. Wang, C., Baker, H.W.G., Burger, H.G., de Kretser, D.M. & Hudson, B. (1975) Hormonal studies in Klinefelter's syndrome. Clinical Endocrinology, 4, 399-411.
166. Weihua, Z., Mäkelä, S., Andersson, L.C., Salmi, S., Saji, S., Webster, J.I., Jensen, E.V., Nilsson, S., Warner, M. & Gustafsson, J.A. (2001) A role for the estrogen receptor β in the regulation of growth of the ventral prostate. Proceedings of the National Academy of Sciences USA, 98, 6330-6335.
167. Windahl, S.H., Vidal, O., Andersson, G., Gustafsson, J.A. & Ohlsson, C. (1999) Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERα-/- mice. Journal of Clinical Investigation, 104, 895-901.
168. Winters, S.J. & Troen, P. (1985) Evidence for a role of endogenous oestrogen in the hypothalamic control of gonadotropin secretion in men. Journal of Clinical Endocrinology and Metabolism, 61, 842-845.
169. Winters, S.J., Janick, J.J., Loriaux, D.L. & Sherins, R.J. (1979) Studies on the role of sex steroids in the feedback control of gonadotropin concentrations in men. II. Use of the oestrogen antagonist, clomiphene citrate. Journal of Clinical Endocrinology and Metabolism, 48, 222-227.
170. Yaffe, K., Lui, L.Y., Grady, D., Cauley, J., Kramer, J. & Cummings, S.R. (2000) Cognitive decline in women in relation to nonprotein-bound oestradiol concentrations. Lancet, 356, 708-712.
171. Young, J., Bulun, S.E., Agarwal, V., Couzinet, B., Mendelson, C.R., Simpson, E.R. & Schaison, G. (1996) Aromatase expression in a feminizing adrenocortical tumor. Journal of Clinical Endocrinology and Metabolism, 81, 3173-3175.
172. Zumoff, B., Strain, G.W., Kream, J., O'Connor, J., Rosenfeld, R.S., Levin, J. & Fukushima, D.K. (1982) Age variation of the 24-hour mean plasma concentrations of androgens, oestrogens nd gonadotrophins in normal adult men. Journal of Clinical Endocrinology and Metabolism, 54, 534-538.